{"id":138509,"date":"2022-12-30T08:45:54","date_gmt":"2022-12-30T13:45:54","guid":{"rendered":"https:\/\/44.250.171.167\/?p=138509"},"modified":"2023-04-25T08:27:19","modified_gmt":"2023-04-25T12:27:19","slug":"vijaya-diagnostic-a-king-in-the-making","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/vijaya-diagnostic-a-king-in-the-making\/","title":{"rendered":"Vijaya Diagnostic: A King in the Making"},"content":{"rendered":"\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>\u201c<em>The second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to enhance its network and make considerable progress on its calibrated expansion plan. The Wellness business is showing positive results and the Company continues to increase its revenue share from this segment. During Q2 FY \u201823, the Wellness segment recorded its highest ever contribution to revenues at 12.4%. This being the case, we are quite sure that the integrated diagnostic service providers derived major business from B2C will not be influenced by competition of different formats.<\/em>\u201d<\/p><cite>&#8211; Suprita Reddy, Chief Executive Officer in the <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/b7d901ff-3fd9-4b23-84eb-e6a57d6e98df.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Q2FY23 Earnings Call<\/a><\/cite><\/blockquote>\n\n\n\n<p>Dr Surendranath Reddy started <a href=\"https:\/\/44.250.171.167\/?post_type=post&amp;s=VIJAYA+-+\" target=\"_blank\" rel=\"noreferrer noopener\">Vijaya Diagnostic<\/a> in 1981. Over the last four decades the company expanded to about 100 centres across Telangana and Andhra Pradesh. In Southern India, Vijaya Diagnostic Centre Ltd. (VDCL)&nbsp; is considered to be the largest integrated diagnostic chain in terms of revenue. It has also made its mark by being one of the fastest &#8211; growing diagnostic chains when it comes to revenue.<\/p>\n\n\n\n<p><strong>Client friendly:<\/strong><\/p>\n\n\n\n<p>Clients are offered one-stop convenient solutions by the company&#8217;s integrated business model of pathology and radiology. Vijaya Diagnostic also has an upper hand in corporate wellness programs and tie-ups owing to the extensive network of spokes and hubs that the company has built around Hyderabad.<\/p>\n\n\n\n<p><strong>Impeccable diagnostic quality :<\/strong><\/p>\n\n\n\n<p>Vijaya&#8217;s high-end quality of equipment and the quality of radiologists they employ is what attributes to the quality edge they have over their peers. Radiology reports heavily rely on the radiologists&#8217; interpretations. Channel checks conducted by us suggest that due to Vijaya\u2019s high quality specialist radiologists, doctors often prefer it as a second opinion while dealing with complex cases. Additionally, attracting new radiologists depends on the calibre of the radiologists already employed as well as the volume of cases that the diagnostic chain can produce. A virtuous loop for the company keeps getting created owing to higher quality radiologists joining Vijaya which leads to higher inflow of cases. As the firm grows, Vijaya is able to continue investing in cutting-edge technology, which boosts sales. Vijaya was a pioneer in introducing high-end equipment technology to the nation.<\/p>\n\n\n\n<p><strong>Large scale business strategy:<\/strong><\/p>\n\n\n\n<p>A \u2018hub and spoke\u2019 model is followed by the company. In this model various specimens from multiple locations get transferred to the company\u2019s national reference laboratory, located beside its flagship Hyderabad centre. It is here that the company produces its findings. This method allows the company to expand its geographical presence with less CAPEX.<\/p>\n\n\n\n<h5 class=\"wp-block-heading\">Overview:<\/h5>\n\n\n\n<p>Owing to the factors mentioned above, in recent years, a total of 20% market share in Hyderabad has been captured by Vijaya alongside foraying into other cities\u00a0 of Andhra Pradesh &amp; Telangana. The company\u2019s continues to possess one of the highest margins within the industry, its focus on B2C (95% of revenue in Q2FY23), and its continued focus on expansion in the regions it dominates, helps us remain optimistic about the company&#8217;s future. Macro factors that include the probability of a quicker market shift to organised companies, synergises these strengths. Greater eastward expansion, particularly in Kolkata, could spur medium- to long-term growth.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cThe second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to enhance its network and make considerable progress on its calibrated expansion plan. The Wellness business is showing positive results and the Company continues to increase its revenue share from this segment. During Q2 FY \u201823, [&hellip;]<\/p>\n","protected":false},"author":1885,"featured_media":138513,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1941,5747],"tags":[8665],"class_list":["post-138509","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock-analysis","category-healthcare-stocks","tag-diagnostics"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/12\/iStock-1408676601.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":130633,"url":"https:\/\/alphastreet.com\/india\/apollo-hospitals-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":138509,"position":0},"title":"Apollo Hospitals Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 14, 2022","format":false,"excerpt":"https:\/\/youtu.be\/o39b8VAmN3k Key highlights from Apollo Hospitals (APOLLOHOSP) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal from Credit Suisse asked what impacted the pharmacy segment margin that was only 6.1% in 4Q22. Obul Reddy CFO said that there was an increase in the customer discount from 10.5% overall last year to\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":143152,"url":"https:\/\/alphastreet.com\/india\/apollo-hospitals-enterprise-limited-q3-fy23-earnings-conference-call-insights\/","url_meta":{"origin":138509,"position":1},"title":"Apollo Hospitals Enterprise Limited Q3 FY23 Earnings Conference Call Insights","author":"Praveen","date":"March 3, 2023","format":false,"excerpt":"Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q3 FY23 Earnings Concall Management Update: [00:02:04] APOLLOHOSP said it had a good 3Q23, with healthcare services growing 10% YonY, excluding vaccines, driven by IT volume growth of 7%. Pricing and case mix also contributed to the growth. [00:03:14] APOLLOHOSP saw an\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":137741,"url":"https:\/\/alphastreet.com\/india\/vijaya-diagnostic-centre-limited-vijaya-q2-fy23-earnings-concall-transcript\/","url_meta":{"origin":138509,"position":2},"title":"Vijaya Diagnostic Centre Limited (VIJAYA) Q2 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"November 11, 2022","format":false,"excerpt":"Vijaya Diagnostic Centre Limited (NSE:VIJAYA) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Suprita Reddy -- Chief Executive Officer Narasimha Raju -- Chief Financial Officer Analysts: Anoop Poojari -- CDR India -- Analyst Unidentified Participant -- -- Analyst Prakash Kapadia -- Anived Portfolio Managers -- Analyst Aneesh Deora\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130579,"url":"https:\/\/alphastreet.com\/india\/medplus-health-services-ltd-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":138509,"position":3},"title":"MedPlus Health Services Ltd Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 9, 2022","format":false,"excerpt":"https:\/\/youtu.be\/9lLLmPN__Yo Key highlights from MedPlus Health Services Ltd (MEDPLUS) Q4 FY22 Earnings Concall Management Update: MEDPLUS said it opened 288 stores in 4Q, the largest quarterly store openings in the company's history. The highest additions were in Tamil Nadu and Maharashtra of 65 and 60 respectively. MEDPLUS commented that it\u2026","rel":"","context":"In &quot;Concall Highlights&quot;","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":137998,"url":"https:\/\/alphastreet.com\/india\/medplus-health-services-ltd-q2-fy23-earnings-concall-transcript\/","url_meta":{"origin":138509,"position":4},"title":"MedPlus Health Services Ltd (MEDPLUS) Q2 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"November 11, 2022","format":false,"excerpt":"MedPlus Health Services Ltd\u00a0(NSE:MEDPLUS) Q2\u00a0FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Gangadi Madhukar Reddy\u00a0--\u00a0Managing Director and Chief Executive Officer Prasad Reddy\u00a0--\u00a0Investor Relations Sujit Kumar Mahato\u00a0--\u00a0Chief Financial Officer Chetan Dikshit\u00a0--\u00a0Chief Strategy Officer Analysts: Aashita Jain\u00a0--\u00a0Nuvama Group -- Analyst Aneesh Deora\u00a0--\u00a0Nomura -- Analyst Ameya Gawande\u00a0--\u00a0Metaverse Equity Fund -- Analyst Prakash\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"stock earnings conference call transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/EarningsTranscript.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":179447,"url":"https:\/\/alphastreet.com\/india\/medplus-health-services-ltd-medplus-q3-2026-earnings-call-transcript\/","url_meta":{"origin":138509,"position":5},"title":"MedPlus Health Services Ltd (MEDPLUS) Q3 2026 Earnings Call Transcript","author":"News desk","date":"February 3, 2026","format":false,"excerpt":"MedPlus Health Services Ltd (NSE: MEDPLUS) Q3 2026 Earnings Call dated Feb. 02, 2026 Corporate Participants: DRN Srinivas: \u2014 Sr. Manager Finance Sujit Kumar Mahato \u2014 Chief Financial Officer Gangadi Madhukar Reddy \u2014 Managing Director and Chief Executive Officer Analysts: Unidentified Participant Gaurav Nigam \u2014 Analyst Presentation: operator Ladies and\u2026","rel":"","context":"In &quot;Earnings Call Transcripts&quot;","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/138509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=138509"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/138509\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/138513"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=138509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=138509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=138509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}